Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 87.30
+0.20 (0.23%)
At close: Aug 12, 2025
Paramount Global Market Cap
Citi Pharma has a market cap or net worth of 20.10 billion as of August 13, 2025. Its market cap has increased by 201.44% in one year.
Market Cap
20.10B
Enterprise Value
21.73B
Revenue
12.97B
Ranking
n/a
PE Ratio
24.19
Stock Price
$87.30
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.10B, an increase of 181.36%. That is a compound annual growth rate of 28.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 20.10B | 29.19% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 136.18B |
| Abbott Laboratories (Pakistan) | 113.57B |
| Highnoon Laboratories | 60.33B |
| AGP Limited | 59.23B |
| The Searle Company | 49.39B |
| Shifa International Hospitals | 35.87B |
| Ferozsons Laboratories | 18.46B |
| Otsuka Pakistan | 3.53B |